Shanghai Henlius Biotech, Inc. (2696.HK), and Organon today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous ...
I'm a 69-year-old woman who's been on different blood pressure medications for a very long time. I was on 20 mg of lisinopril and 5 mg of amlodipine ...
Amgen is projected to report a nearly 3% fall in its Q1 earnings on April 30, after the closing bell. The consensus EPS Estimate is $4.77, while the revenue estimate is $8.57B, tr ...
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution
Q1 2026 revenues of ~$4.0 billion increased by 2% in U.S. dollars year-over-year (YoY), and decreased by 3% in local currency terms (LC). Excluding the Japan business venture (BV) results, revenues ...
We just covered 15 Under-the-Radar Picks from David Einhorn That Are Quietly Dominating 2026 and Teva Pharmaceutical ...
New clinical guidance and research highlight the importance of vitamin D and calcium, targeted exercise, and updated osteoporosis treatments to protect bone health in aging adults. Studies warn of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results